1-[3-[2-(2-methoxyanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]-3-(2-morpholin-4-ylethyl)urea
C26H29N7O3 — CID 53234984
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[3-[2-(2-methoxyanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]-3-(2-morpholin-4-ylethyl)urea
1-[3-[2-(2-methoxyanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]-3-(2-morpholin-4-ylethyl)urea (PubChem CID 53234984) has the molecular formula C26H29N7O3 and a molecular weight of 487.56 g/mol. Its IUPAC name is 1-[3-[2-(2-methoxyanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]-3-(2-morpholin-4-ylethyl)urea.
Molecular Properties
| Compound Name | 1-[3-[2-(2-methoxyanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]-3-(2-morpholin-4-ylethyl)urea |
|---|---|
| PubChem CID | 53234984 |
| Molecular Formula | C26H29N7O3 |
| Molecular Weight | 487.56 g/mol |
| Exact Mass | 487.23 |
| IUPAC Name | 1-[3-[2-(2-methoxyanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]-3-(2-morpholin-4-ylethyl)urea |
| SMILES | COc1ccccc1Nc1nc2ccc(-c3cccc(NC(=O)NCCN4CCOCC4)c3)cn2n1 |
| InChI | InChI=1S/C26H29N7O3/c1-35-23-8-3-2-7-22(23)29-25-30-24-10-9-20(18-33(24)31-25)19-5-4-6-21(17-19)28-26(34)27-11-12-32-13-15-36-16-14-32/h2-10,17-18H,11-16H2,1H3,(H,29,31)(H2,27,28,34) |
| InChIKey | PLPQEDQEJGMAPL-UHFFFAOYSA-N |
| XLogP | 3.60 |
| TPSA | 105.05 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 487.56 |
| LogP ≤ 5 | 3.60 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 53234984 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.